Dr. Chandra Tayade is an Assistant Professor in the Department of at Queen’s University. Dr. Tayade received his DVM (Doctor of Veterinary Medicine) from Nagpur Veterinary College and PhD from Indian Veterinary Research Institute, Izatnagar, India. He then worked as a Scientist with Government of India for two years. Dr. Tayade finished postdoctoral training with Dr. Anne Croy at the University of Guelph in reproductive immunology and became Assistant Professor in the Department of Biomedical Sciences. In 2009, he joined tenure-track faculty position in the Department of Biomedical and Molecular Sciences at Queen’s University.
Dr. Tayade’s research is focused on understanding the pathophysiology of endometriosis. Specifically he is interested in defining the association of immune mechanisms with neoangiogenesis and survival of endometriotic lesions. One of the key components of new blood vessel formation is recruitment of endothelial and hematopoietic progenitor cells from bone marrow to the neoangiogenic sites. His laboratory is investigating specific mechanisms supporting blood vessel growth in endometriosis that can be safely targeted using anti-angiogenic therapies. He has established a new mouse xenogenic engraftment model and currently validating the efficacy of several anti-angiogenic compounds. His laboratory uses a combination of molecular biology approaches, patient-based studies and immunodeficient mouse models. Dr. Tayade’s research is supported by grants from Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council, Canada Foundation for Innovation, Ministry of Research and Innovation and Industrial awards from Bioniche Life Sciences, Inc. Dr. Tayade is recipient of J. Christian Herr Award from the American Society for Reproductive Immunology for outstanding research contribution.